Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll

July 08, 2014

FDA Weighs In on Social Media

The FDA recently issued two draft guidances on the use of social medial by pharmaceutical and biotechnology companies. One focuses on presenting risk-and-benefit information for drugs or devices and the other offers advice for dealing with misinformation spread on third-party sites. (For more on this, click here.)

Do you think the FDA needs to have as strict a stance on social media outlets as it does on traditional communication modes of regulatory information?

  {{ choice.Percent }}%